To summarize, CD36 can synergize the pro-cancer effects of TAMs via multiple mechanisms, suggesting that targeting CD36 to modulate the oxidation and polarization of TAMs may be an effective therapeutic strategy. This evidence concerns the gene CD36 and cancer.